Quantcast

Latest Diabetes mellitus type 1 Stories

2014-09-03 12:29:59

TORONTO, Sept. 3, 2014 /CNW/ - Keeping children with diabetes safe, healthy and fully involved in school activities is the goal of the following initiatives being announced today by the International Diabetes Federation (IDF) and the Canadian Diabetes Association (CDA) in Toronto: -- The North American launch of the global Kids and Diabetes in Schools (KiDS) project and information pack offering resources to teachers, children and parents...

2014-08-28 08:28:11

PLAINSBORO, N.J., Aug. 28, 2014 /PRNewswire/ -- Results from an analysis of US respondents from Novo Nordisk's Diabetes Attitudes, Wishes and Needs 2 (DAWN2(TM)) study were published recently in Current Medical Research and Opinion. The study shows that minority populations in the US with diabetes, including African Americans, Chinese Americans, and Hispanics, reported positive psychological well-being, better quality of life, and feeling more empowered with respect to their diabetes...

2014-08-27 08:25:07

Dr. Mitchell Gibson's new book explores the scientific and spiritual effects of sunlight on the human body. HIGH POINT, N.C., Aug. 27, 2014 /PRNewswire/ -- Sunlight has long been a source of rejuvenation and health for billions of people all over the world. Recently, modern scientists have begun to take a new look at the power of the sun to address a number of ailments that have distressed mankind. Sunlight therapy dates back to the time of the ancient Greeks when it was called...

2014-08-26 23:10:27

The Western Pennsylvania Chapter of JDRF has named Susan Manzi, MD, Chair of the Department of Medicine at Allegheny Health Network, corporate chair of its 2014 Walk to Cure Diabetes event in Pittsburgh. Pittsburgh, PA (PRWEB) August 26, 2014 The Western Pennsylvania Chapter of JDRF has named Susan Manzi, MD, Chair of the Department of Medicine at Allegheny Health Network, corporate chair of its 2014 Walk to Cure Diabetes event in Pittsburgh. The JDRF Walk to Cure Diabetes in Pittsburgh...

2014-08-26 08:31:41

New JARDIANCE Simple Savings program currently offered in doctors' offices and online RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 26, 2014 /PRNewswire/ -- Jardiance(®) (empagliflozin) tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY). The U.S. Food and Drug Administration...

2014-08-26 08:30:35

SAN DIEGO, Aug. 26, 2014 /PRNewswire/ -- Profil Institute for Clinical Research, Inc., an early phase clinical research organization (CRO) focused on diabetes and obesity, announced today a milestone in clinical research for diabetes with the completion of more than 200 phase I - IIa clinical trials encompassing every clinically relevant drug class for the treatment of type 1 and type 2 diabetes. "The significance of this vast amount of research is what it represents for the public...

2014-08-25 23:07:22

The University of Iowa celebrated the dedication of the Fraternal Order of Eagles Diabetes Research Center (FOE DRC) on August 23, 2014. With 100 researchers and the most advanced laboratories and medical technology, the new facility will pursue innovative diabetes research and find treatments and cures for the epidemic that affects more than 9 percent of the American population. Iowa City, IA (PRWEB) August 25, 2014 The University of Iowa celebrated the dedication of the Fraternal Order...

2014-08-21 08:29:07

SAN DIEGO, Aug. 21, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company announced today that it has entered into a Rights Agreement with Janssen Research & Development LLC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01(TM) combination product that ViaCyte is developing for type 1 diabetes. This right will continue...

2014-08-20 08:27:26

SOUTHAMPTON, England, August 20, 2014 /PRNewswire/ -- Phase I Trial of Plasma Kallikrein Inhibitor to be Conducted in the US KalVista Pharmaceuticals ("KalVista"), an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME. The study's Principal Investigator is Dr. Jennifer K Sun of the Beetham Eye Institute, Joslin...

2014-08-19 08:30:47

Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug. 19, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its VC-01(TM) candidate cell replacement therapy to treat type 1 diabetes. The company plans to promptly initiate a Phase 1/2 clinical trial which it believes to be the first...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'